Related Experiment Video
Updated: Aug 6, 2026

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy
Published on: July 29, 2019
Cholinergic basal forebrain modulation of glymphatic function: implications for depression
Yirong Fang1, Zeyu Lu1, Xian Chao1
1Department of Neurology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
The cholinergic basal forebrain (ChBF) regulates brain glymphatic function, impacting depression. This discovery offers new therapeutic targets for depression by focusing on glymphatic system enhancement.
Area of Science:
- Neuroscience
- Neuroimaging
- Psychiatry
Background:
- Glymphatic system dysfunction is linked to depression, but its regulation is unknown.
- The cholinergic basal forebrain (ChBF) is a potential regulator of glymphatic function and depression.
Purpose of the Study:
- To investigate the regulatory role of the ChBF in glymphatic function and its connection to depression.
- To test the hypothesis that ChBF modulates glymphatic function, influencing depression.
Main Methods:
- Utilized multimodal neuroimaging (MRI, fMRI) in stroke and non-stroke cohorts.
- Assessed glymphatic function using DTI-ALPS index and gBOLD-CSF coupling.
- Employed lesion network mapping and transcranial magnetic stimulation (TMS).
Main Results:
- ChBF functional connectivity (FC) predicted glymphatic impairment and recovery.
- Glymphatic dysfunction mediated the link between ChBF damage and post-stroke depression.
- Enhanced ChBF FC correlated with antidepressant efficacy and glymphatic improvement.
Conclusions:
- The ChBF plays a key regulatory role in glymphatic function.
- Glymphatic function influences depression, suggesting it as a therapeutic target.
- Findings support developing glymphatic-based depression therapies.
More Related Videos
07:56Photobiomodulation Under Electroencephalographic Controls of Sleep for Stimulation of Lymphatic Removal of Toxins from Mouse Brain
Published on: June 28, 2024
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Gut-Brain Axis
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Pharmacological Actions